Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
US8513231B2 · kind B2 · utility
1Cited by
8References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2012 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Aug 28, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.